BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29516685)

  • 21. Detection of thyroid-stimulating hormone receptor and Gsalpha mutations: in 75 toxic thyroid nodules by denaturing gradient gel electrophoresis.
    Trülzsch B; Krohn K; Wonerow P; Chey S; Holzapfel HP; Ackermann F; Führer D; Paschke R
    J Mol Med (Berl); 2001; 78(12):684-91. PubMed ID: 11434721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular Testing for miRNA, mRNA, and DNA on Fine-Needle Aspiration Improves the Preoperative Diagnosis of Thyroid Nodules With Indeterminate Cytology.
    Labourier E; Shifrin A; Busseniers AE; Lupo MA; Manganelli ML; Andruss B; Wylie D; Beaudenon-Huibregtse S
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2743-50. PubMed ID: 25965083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A morpho-molecular diagnosis of papillary thyroid carcinoma: BRAF V600E detection as an important tool in preoperative evaluation of fine-needle aspirates.
    Marchetti I; Lessi F; Mazzanti CM; Bertacca G; Elisei R; Coscio GD; Pinchera A; Bevilacqua G
    Thyroid; 2009 Aug; 19(8):837-42. PubMed ID: 19534623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contribution of the BRAF mutation analysis in calcified thyroid nodules.
    Yoo EY; Shin JH; Ko EY; Han BK
    AJR Am J Roentgenol; 2012 Apr; 198(4):891-5. PubMed ID: 22451557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What to do with thyroid nodules showing benign cytology and BRAF(V600E) mutation? A study based on clinical and radiologic features using a highly sensitive analytic method.
    Kim SY; Kim EK; Kwak JY; Moon HJ; Yoon JH
    Surgery; 2015 Feb; 157(2):354-61. PubMed ID: 25616949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does addition of BRAF V600E mutation testing modify sensitivity or specificity of the Afirma Gene Expression Classifier in cytologically indeterminate thyroid nodules?
    Kloos RT; Reynolds JD; Walsh PS; Wilde JI; Tom EY; Pagan M; Barbacioru C; Chudova DI; Wong M; Friedman L; LiVolsi VA; Rosai J; Lanman RB; Kennedy GC
    J Clin Endocrinol Metab; 2013 Apr; 98(4):E761-8. PubMed ID: 23476074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The value of multi-gene testing in benign or malign diagnosis of thyroid nodules with indeterminate cytology].
    Song YT; Xu GH; Zhu YL; Ma TH; Yu H; Wang TX; Yu WB; Wei W; Zhang B
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Oct; 54(10):764-768. PubMed ID: 31606990
    [No Abstract]   [Full Text] [Related]  

  • 28. Malignant risk stratification of thyroid FNA specimens with indeterminate cytology based on molecular testing.
    Paskaš S; Janković J; Živaljević V; Tatić S; Božić V; Nikolić A; Radojković D; Savin S; Cvejić D
    Cancer Cytopathol; 2015 Aug; 123(8):471-9. PubMed ID: 25924719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of molecular testing in fine-needle aspiration biopsy samples: an experience in a Chinese population.
    Liu S; Gao A; Zhang B; Zhang Z; Zhao Y; Chen P; Ji M; Hou P; Shi B
    Exp Mol Pathol; 2014 Oct; 97(2):292-7. PubMed ID: 25111330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical results of thyroid nodules according to a management guideline based on the BRAF(V600E) mutation status.
    Kim SK; Hwang TS; Yoo YB; Han HS; Kim DL; Song KH; Lim SD; Kim WS; Paik NS
    J Clin Endocrinol Metab; 2011 Mar; 96(3):658-64. PubMed ID: 21239517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overview of molecular biomarkers for enhancing the management of cytologically indeterminate thyroid nodules and thyroid cancer.
    Duick DS
    Endocr Pract; 2012; 18(4):611-5. PubMed ID: 22849877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperfunctioning thyroid nodules in toxic multinodular goiter share activating thyrotropin receptor mutations with solitary toxic adenoma.
    Tonacchera M; Chiovato L; Pinchera A; Agretti P; Fiore E; Cetani F; Rocchi R; Viacava P; Miccoli P; Vitti P
    J Clin Endocrinol Metab; 1998 Feb; 83(2):492-8. PubMed ID: 9467563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High prevalence of TSHR/Gsα mutation-negative clonal hot thyroid nodules (HNs) in a Turkish cohort.
    Sancak S; Jaeschke H; Eren F; Tarcin O; Guellueoglu B; Sen LS; Sever Z; Gozu HI; Bircan R; Akalin S; Paschke R; Eszlinger M
    Horm Metab Res; 2011 Jul; 43(8):562-8. PubMed ID: 21773967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of malignancy in cytologically indeterminate thyroid nodules harboring thyroid stimulating hormone receptor mutations.
    Whitmer D; Phay JE; Holt S; O'Donnell B; Nguyen J; Joseph D; Chi A; Wu S; Hao Y; Huang J; Klopper JP; Kloos RT; Kennedy GC; Shin J
    Front Endocrinol (Lausanne); 2022; 13():1073592. PubMed ID: 36619548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two novel mutations in the sixth transmembrane segment of the thyrotropin receptor gene causing hyperfunctioning thyroid nodules.
    Gozu H; Avsar M; Bircan R; Claus M; Sahin S; Sezgin O; Deyneli O; Paschke R; Cirakoglu B; Akalin S
    Thyroid; 2005 Apr; 15(4):389-97. PubMed ID: 15876166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted Next Generation Sequencing with ThyroSeq v2.1 for Indeterminate Thyroid Nodules in Clinical Practice.
    Witt RL
    Del Med J; 2016 Dec; 88(12):366-372. PubMed ID: 29461717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensitive Sequencing Analysis Suggests Thyrotropin Receptor and Guanine Nucleotide-Binding Protein G Subunit Alpha as Sole Driver Mutations in Hot Thyroid Nodules.
    Stephenson A; Eszlinger M; Stewardson P; McIntyre JB; Boesenberg E; Bircan R; Sancak S; Gozu HI; Ghaznavi S; Krohn K; Paschke R
    Thyroid; 2020 Oct; 30(10):1482-1489. PubMed ID: 32284013
    [No Abstract]   [Full Text] [Related]  

  • 38. Correlation Between Histological Diagnosis and Mutational Panel Testing of Thyroid Nodules: A Two-Year Institutional Experience.
    Shrestha RT; Evasovich MR; Amin K; Radulescu A; Sanghvi TS; Nelson AC; Shahi M; Burmeister LA
    Thyroid; 2016 Aug; 26(8):1068-76. PubMed ID: 27283257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Somatic mutations in the thyrotropin receptor gene and not in the Gs alpha protein gene in 31 toxic thyroid nodules.
    Führer D; Holzapfel HP; Wonerow P; Scherbaum WA; Paschke R
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3885-91. PubMed ID: 9360556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative cytology with molecular analysis to help guide surgery for pediatric thyroid nodules.
    Buryk MA; Monaco SE; Witchel SF; Mehta DK; Gurtunca N; Nikiforov YE; Simons JP
    Int J Pediatr Otorhinolaryngol; 2013 Oct; 77(10):1697-700. PubMed ID: 23993207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.